Haleon HLN
NYSE HLN
$9.91 +0.05 (+0.46%)
At close: Aug 20, 2026 · 11:52 AM UTC

Haleon (HLN) Total Current Liabilities (2021 - 2026)

Haleon's (HLN) quarterly Total Current Liabilities came in at -$8.4 billion in Q2 2026, down 26.75% on a QoQ basis from -$6.6 billion in Q4 2025.

Haleon (HLN) Total Current Liabilities (2021 - 2026) Analysis & Trends

Haleon (HLN) has 6 years of Total Current Liabilities data on file, last reported at -$8.4 billion in Q2 2026.

  • Quarterly Total Current Liabilities changed N/A year-over-year to -$8.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$8.4 billion (changed N/A YoY) and the FY2025 annual result came in at -$6.6 billion, down 188.32% from the prior year.
  • Total Current Liabilities fell to -$8.4 billion in Q2 2026, from -$6.6 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $7.5 billion in Q4 2024 to a low of -$8.4 billion in Q2 2026.
  • A 5-year average of -$1.9 billion and a median of -$5.8 billion in 2022 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities grew 29.53% — and 2025, when it tumbled 188.6%.
  • Tracing HLN's Total Current Liabilities over 5 years: stood at $5.1 billion in 2022, then advanced by 12.35% to $5.8 billion in 2023, then gained by 29.53% to $7.5 billion in 2024, then slumped by 188.6% to -$6.6 billion in 2025, then retreated by 26.75% to -$8.4 billion in 2026.
  • The last three Total Current Liabilities figures came in at -$8.4 billion (Q2 2026), -$6.6 billion (Q4 2025), and $7.5 billion (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -8.38 Bn
2 Teva Pharmaceutical Industries 43.42 Bn 39.76 Bn 2.15 Bn 15.65 Bn
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn 2.06 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.98 Bn 5.10 Bn 17.34 Bn
5 United Therapeutics 22.29 Bn 19.63 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.78 Bn 17.89 Bn 1.46 Bn 6.35 Bn
7 Neurocrine Biosciences 15.66 Bn 15.27 Bn 935.80 Mn 874.50 Mn
8 Elanco Animal Health 11.91 Bn 11.38 Bn 798.00 Mn 1.85 Bn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - 1.79 Bn
10 Alkermes 8.20 Bn 7.55 Bn 397.90 Mn 662.09 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.38 Bn
Dec 31, 2025 -6.61 Bn
Dec 31, 2024 7.46 Bn
Jun 30, 2024 -7.10 Bn
Dec 31, 2023 5.76 Bn
Jun 30, 2023 -6.24 Bn
Dec 31, 2022 5.13 Bn
Jun 30, 2022 -5.29 Bn
Dec 31, 2021 5.71 Bn